Managed Markets
Network

Introducing a new FDA-approved therapy for relapsed/refractory AML | AJMC® is seeking submissions on the following clinical topics: Immunology, Oncology, Diabetes, Neurology, Infectious Diseases, and Respiratory Diseases. Submit your research today!

Library of articles. Archived since 2004.

Value-Based Insurance Design

Value in the News

CGRP Inhibitor Erenumab Gains EU Approval for Migraine Prevention
Value-Based Pricing Is in Place, but Prices for a Single Drug Vary
Report Finds Medicare Hospice Program Beset With Quality, Care Issues
FDA Finalizes Guidance on Use of EHR Data in Clinical Investigations
Value-Based Pricing Is in Place, but Prices for a Single Drug Vary
HIV Comorbidities Associated With More Hospitalizations, Increased Costs
View More >
Library of articles. Archived since 2004.

Value Assessment

Library of articles. Archived since 2004.

Value-Based Purchasing

ACCOUNTABLE CARE DELIVERY CONGRESS
CONTINUING EDUCATION
CONTRIBUTORS
MEETINGS
PARTICIPATE
COMPENDIA
In Focus Blog
Press Releases
Interactive Tools
Managed Care Podcast
Panel Discussions
Week In Review
Information for Reviewers
Information for Authors
Formulary Central
Clinical Study Summaries
Study Summaries
About Us
AJAC
AJMC
EBDM
EBO
AJMC Resources
Careers
Contact Us
Privacy Policy
Terms & Conditions
Subscribe
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
×

Sign In

Not a member? Sign up now!